1. Home /
  2. Biotechnology

Biotechnology

Biogen Could Go Either Way - Mixed Indicators and Charts

Biogen Could Go Either Way - Mixed Indicators and Charts

Let's check to see what can be gleaned.

Edwards Lifesciences Gains on Positive Heart Trial Results

Edwards Lifesciences Gains on Positive Heart Trial Results

The medical research and device company announces positive results from its recent aortic valve surgical treatment trial.

My Post-Earnings Assessment of 2 Biotech Stocks

My Post-Earnings Assessment of 2 Biotech Stocks

Let's look at a couple of companies we have covered on these pages before.

Sarepta Therapeutics' Charts Look Risky

Sarepta Therapeutics' Charts Look Risky

In a red flag for investors, the charts show sellers are getting more aggressive with Sarepta.

Infusion Therapy Firm BioScrip to Buy Rival Option Care

Infusion Therapy Firm BioScrip to Buy Rival Option Care

BioScrip agrees to buy rival Option Care Enterprises, creating one of the largest independent home-therapy companies in the U.S.

What Is the Internet of Things and Why Is It Essential in 2019?

What Is the Internet of Things and Why Is It Essential in 2019?

The Internet of Things promises to merge the physical and data worlds together. This is why that's a good thing.

Positive Breadth Helps Momentum Continue Despite Boeing's Woes

Positive Breadth Helps Momentum Continue Despite Boeing's Woes

Strength in Apple and other FANG names are pluses, as are pockets of action in gold mining, cannabis, biotechnology and shipping.

Lannett Rises After Announcing Adderall Distribution Agreement

Lannett Rises After Announcing Adderall Distribution Agreement

Lannett rises after the drugmaker enters an agreement with two other pharmaceutical players to sell a generic form of Adderall.

Exact Sciences Looks Vulnerable: Protect Longs

Exact Sciences Looks Vulnerable: Protect Longs

Shares of Exact Sciences has been on the upswing, but the stock price of the cancer screening test firm may be vulnerable.

Insider Buying Is Still Alive and Well at These 3 Companies

Insider Buying Is Still Alive and Well at These 3 Companies

Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.